17 Mar 2020 --- Germany-based Evonik has developed an advanced collagen platform produced via fermentation-based processes without any animal or human-derived ingredients. So far, the production of “vegan” collagen has been a challenge for the industry, but major players are making moves in the space. Evonik notes that the new, recombinant technology will provide the pharmaceutical, medical, cell culture and tissue engineering markets with a highly soluble, ultra-pure form of collagen that is safe, sustainable and commercially scalable.
